F098 Chronic Spontaneous Urticaria: A Review of the Basics and New and Emerging Drugs
DESCRIPTION
This session will review the pathophysiology of chronic spontaneous urticaria (CSU), and how new and emerging drugs will target this disease. Attendees will also learn how to assess and document the severity of CSU.
LEARNING OBJECTIVES
Recognize the pathophysiology and burden of chronic spontaneous urticaria
Describe the physician and patient reported outcomes measures used in chronic spontaneous urticaria trials
Prepare your practice for new and emerging drugs in the chronic spontaneous urticaria space
SCHEDULE
3:30 PM
Introduction
Walter Liszewski, MD, FAAD
3:40 PM
Pathophysiology of chronic urticaria
Naiem Issa, MD, PhD, FAAD
4:05 PM
Diagnosis and workup of chronic urticaria
Walter Liszewski, MD, FAAD
4:25 PM
Treatment of chronic urticaria
Walter Liszewski, MD, FAAD
4:45 PM
New and emerging drugs in chronic urticaria
Jason Ezra Hawkes, MD, MS, FAAD
5:05 PM
Sample cases and conundrums in chronic urticaria
5:15 PM
Q & A
DIRECTOR
Walter Liszewski, MD, FAAD
SPEAKERS
Jason Ezra Hawkes, MD, MS, FAAD
Oregon Medical Research Center
Naiem Issa, MD, PhD, FAAD
DISCLOSURES
Jason Ezra Hawkes, MD, MS, FAAD
AbbVie – Advisory Board(Fees), Investigator(Grants/Research Funding); Acelyrin – Investigator(Grants/Research Funding); Allakos – Investigator(Grants/Research Funding); Alumis – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Fees); Blueprint Medicines – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Incyte – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Kymera Therapeutics – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding), Speaker(Fees), Speaker(Honoraria); Novartis – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker/Faculty Education(Honoraria); Organon – Advisory Board(Honoraria), Speaker(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Speaker(Honoraria), Stockholder(Stock); Sanofi Genzyme – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria);
Naiem Issa, MD, PhD, FAAD
AbbVie – Speaker(Fees); Almirall – Advisory Board(Fees), Speaker(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Speaker(Fees); Botanix Pharmaceuticals – Speaker(Fees); Bristol Myers Squibb – Advisory Board(Fees), Speaker(Fees); Castle Biosciences – Advisory Board(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees), Speaker(Fees); DermTech Inc. – Consultant (1099 relationship)(Fees), Speaker(Fees); Eli Lilly – Advisory Board(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Fees); Incyte Corporation – Speaker(Fees); Journey Medical Corporation – Consultant (1099 relationship)(Fees), Speaker(Fees); LEO Pharma, US – Advisory Board(Fees), Speaker(Fees); National Eczema Association – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees), Speaker(Fees); Ortho Dermatologics – Speaker(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Sanofi/Regeneron – Speaker(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees), Speaker(Fees); Topix Pharmaceuticals, Inc. – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Speaker(Fees), Stockholder Public Company(Stock);
Walter Liszewski, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Eli Lilly – Speaker(Honoraria); Galderma – Speaker(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Leo Foundation – Consultant (1099 relationship)(Honoraria); Regeneron – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Honoraria);